Clinical status of patients 1 year after hospital discharge following recovery from COVID-19 : a prospective cohort study

© 2022. The Author(s)..

BACKGROUND: The long-term clinical status of coronavirus disease 2019 (COVID-19) in recovered patients remains largely unknown. This prospective cohort study evaluated clinical status of COVID-19 and explored the associated risk factors.

METHODS: At the outpatient visit, patients underwent routine blood tests, physical examinations, pulmonary function tests, 6-min walk test, high-resolution computed tomography (CT) of the chest, and extrapulmonary organ function tests.

RESULTS: 230 patients were analyzed. Half (52.7%) reported at least one symptom, most commonly fatigue (20.3%) and sleep difficulties (15.8%). Anxiety (8.2%), depression (11.3%), post-traumatic symptoms (10.3%), and sleep disorders (26.3%) were also reported. Diffusion impairments were found in 35.4% of the patients. Abnormal chest CT scans were present in 63.5% of the patients, mainly reticulation and ground-glass opacities. Further, a persistent decline in kidney function was observed after discharge. SARS-CoV-2-specific antibodies of IgA, IgG, and IgM were positive in 56.4%, 96.3%, and 15.2% of patients, respectively. Multivariable logistic regression showed that disease severity, age, and sex were closely related to patient recovery.

CONCLUSIONS: One year after hospital discharge, patients recovered from COVID-19 continued to experience both pulmonary and extrapulmonary dysfunction. While paying attention to pulmonary manifestations of COVID-19, follow-up studies on extrapulmonary manifestations should be strengthened.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Annals of intensive care - 12(2022), 1 vom: 10. Juli, Seite 64

Sprache:

Englisch

Beteiligte Personen:

Li, Dapeng [VerfasserIn]
Liao, Xuejiao [VerfasserIn]
Ma, Zhenghua [VerfasserIn]
Zhang, Lina [VerfasserIn]
Dong, Jingke [VerfasserIn]
Zheng, Guoqin [VerfasserIn]
Zi, Mei [VerfasserIn]
Peng, Wujian [VerfasserIn]
Wei, Lanlan [VerfasserIn]
Li, Zhiyan [VerfasserIn]
Kong, Yingjun [VerfasserIn]
Wang, Lifei [VerfasserIn]
Liu, Dongjing [VerfasserIn]
Wang, Fang [VerfasserIn]
He, Qing [VerfasserIn]
Li, Guobao [VerfasserIn]
Zhang, Zheng [VerfasserIn]
Liu, Lei [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Extrapulmonary dysfunction
Journal Article
Pulmonary dysfunction
Risk factor
SARS-CoV-2 antibodies

Anmerkungen:

Date Revised 30.08.2022

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1186/s13613-022-01034-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM343366967